Merck & Co., Inc.
MRK
$115.88
$2.882.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.77B | 65.01B | 64.24B | 63.62B | 63.92B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.77B | 65.01B | 64.24B | 63.62B | 63.92B |
| Cost of Revenue | 15.31B | 14.82B | 14.23B | 14.37B | 14.66B |
| Gross Profit | 50.46B | 50.20B | 50.01B | 49.25B | 49.27B |
| SG&A Expenses | 10.28B | 10.11B | 10.07B | 10.13B | 10.19B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.13B | 40.44B | 36.95B | 39.01B | 38.86B |
| Operating Income | 24.63B | 24.57B | 27.29B | 24.61B | 25.07B |
| Income Before Tax | 11.63B | 21.07B | 21.82B | 19.16B | 20.17B |
| Income Tax Expenses | 2.70B | 2.81B | 2.77B | 2.74B | 2.72B |
| Earnings from Continuing Operations | 8.93K | 18.26K | 19.04K | 16.42K | 17.45K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | -8.00M | -10.00M | -12.00M | -17.00M |
| Net Income | 8.94B | 18.25B | 19.03B | 16.41B | 17.43B |
| EBIT | 24.63B | 24.57B | 27.29B | 24.61B | 25.07B |
| EBITDA | 29.62B | 29.21B | 31.62B | 28.99B | 29.45B |
| EPS Basic | 3.56 | 7.29 | 7.57 | 6.50 | 6.89 |
| Normalized Basic EPS | 5.84 | 5.85 | 6.52 | 5.91 | 6.00 |
| EPS Diluted | 3.55 | 7.28 | 7.56 | 6.49 | 6.87 |
| Normalized Diluted EPS | 5.83 | 5.84 | 6.51 | 5.90 | 5.99 |
| Average Basic Shares Outstanding | 9.97B | 10.02B | 10.07B | 10.10B | 10.13B |
| Average Diluted Shares Outstanding | 9.97B | 10.03B | 10.08B | 10.12B | 10.15B |
| Dividend Per Share | 3.28 | 3.24 | 3.20 | 3.16 | 3.12 |
| Payout Ratio | 92.12% | 44.79% | 42.60% | 48.95% | 45.54% |